X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.1	9.19	26.75	16.16	28.01	43.42
Cash & Short-Term Investments	1.1	9.19	26.75	16.16	28.01	43.42
Cash Growth	-41.05%	-65.63%	65.57%	-42.33%	-35.48%	-19.22%
Accounts Receivable	0.19	34.63	0.59	3.71	5.07	3.71
Other Receivables	10.09	15.6	28.56	14.12	18.19	11.04
Receivables	10.28	50.23	29.15	17.83	23.26	14.75
Inventory	2.41	11.87	6.76	13.09	35.12	20.23
Prepaid Expenses	1.1	3.19	1.43	1.54	3.28	2.62
Other Current Assets	430.16	32.69	7.09	6.51	9.8	8.69
Total Current Assets	445.05	107.17	71.19	55.12	99.47	89.71
Property, Plant & Equipment	111.35	596.29	213.87	173.56	294.62	226.12
Goodwill	123.39	335.35	246.18	267.44	516.1	516.1
Other Intangible Assets	71.71	319.23	146.54	150.05	364.85	414.37
Long-Term Deferred Tax Assets	-	0.13	-	-	-	-
Other Long-Term Assets	42.53	56.17	61.6	53.92	45.55	34.24
Total Assets	794.03	1,414	739.39	700.09	1,321	1,281
Accounts Payable	129.36	46.65	28.22	29.54	71.01	35.52
Accrued Expenses	-	39.3	38.33	25.24	17.5	10.17
Short-Term Debt	272.34	251.86	293.24	340.34	301.54	66.96
Current Portion of Long-Term Debt	2.98	3.05	3.05	3.21	3.14	1.44
Current Portion of Leases	16.61	22.16	26.64	27.23	36.39	23.25
Current Unearned Revenue	-	6.12	1.68	0.38	0.3	0.83
Other Current Liabilities	-	64.14	35.02	31.17	28.05	21.14
Total Current Liabilities	421.29	433.26	426.2	457.12	457.94	159.31
Long-Term Debt	4.31	5.93	8.29	10.68	13.2	9.47
Long-Term Leases	40.9	71.57	83.81	91.51	114.78	100.36
Long-Term Unearned Revenue	-	-	-	-	-	0.02
Pension & Post-Retirement Benefits	6.15	5.4	3.25	2.3	6.95	6.19
Long-Term Deferred Tax Liabilities	13.86	64.88	27.88	29.01	34.65	40.3
Other Long-Term Liabilities	4.32	5.88	7.15	6.94	19.66	16.78
Total Liabilities	490.82	586.93	556.58	597.55	647.19	332.44
Common Stock	2,098	1,944	1,031	813.91	813.91	12,209
Retained Earnings	-1,638	-1,376	-1,116	-968.77	-397.91	-939.72
Comprehensive Income & Other	-163.6	-53.66	268.5	257.4	257.4	-10,321
Total Common Equity	296.55	513.52	182.8	102.54	673.4	948.1
Minority Interest	6.66	313.91	0	0	0	0
Shareholders' Equity	303.21	827.43	182.81	102.54	673.41	948.11
Total Liabilities & Equity	794.03	1,414	739.39	700.09	1,321	1,281
Total Debt	337.14	354.56	415.04	472.98	469.05	201.48
Net Cash (Debt)	-336.04	-345.37	-388.29	-456.82	-441.04	-158.06
Net Cash Per Share	-1.20	-1.88	-3.10	-3.93	-3.79	-1.63
Filing Date Shares Outstanding	299.7	277.66	147.23	116.27	116.27	116.27
Total Common Shares Outstanding	299.7	277.66	147.23	116.27	116.27	116.27
Working Capital	23.77	-326.09	-355.01	-402	-358.47	-69.6
Book Value Per Share	0.99	1.85	1.24	0.88	5.79	8.15
Tangible Book Value	101.45	-141.06	-209.92	-314.95	-207.55	17.63
Tangible Book Value Per Share	0.34	-0.51	-1.43	-2.71	-1.79	0.15
Land	-	126	-	-	-	-
Machinery	-	354.01	70.33	72.44	123.46	101.12
Construction In Progress	-	8.56	16.51	2.3	11.08	3.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.